logo
A New Study Found That This Morning Beverage Can Improve Your Gut Health Almost Instantly

A New Study Found That This Morning Beverage Can Improve Your Gut Health Almost Instantly

Yahoo16-03-2025

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links."
Sipping on a cup of joe is an easy way to infuse some much-need pleasure into a hectic morning or slow afternoon at work. But a growing body of research suggests that coffee might do your physical health a solid, too, even helping your gut cultivate some great bacteria.
A new study, which was published in Nature Microbiogy, found that a coffee habit is linked with a certain type of bacteria growth that's believed to boost your gut health. However, the link is a little complicated. So, with that in mind, here's what the study found, plus what doctors want you to know.
Meet the experts: Danbee Kim, MD, nutrition expert, weight loss surgeon, and assistant professor at Rutgers New Jersey Medical School; Nicola Segata, PhD, study co-author, professor, and principal investigator at the CIBIO Department of the University of Trento; Rudolph Bedford, MD, a gastroenterologist at Providence Saint John's Health Center in Santa Monica, CA
For the study, researchers analyzed fecal (i.e. poop) data from more than 20,000 people and tracked how much coffee they consumed on a daily basis.
The researchers found that people who regularly drank coffee also had a bacterium called Lawsonibacter asaccharolyticus in their gut.
'People who drink coffee, on average, have a six to eight times higher amount of this bacterium in the gut,' says Nicola Segata, PhD, study co-author, professor, and principal investigator at the CIBIO Department of the University of Trento.
We don't actually know a ton about L. asaccharolyticus. The bacterium was first identified in research in 2018. It produces butyrate, a sign of gut fermentation that suggests good digestion and nutrient absorption, Segata explains.
"It's probably producing short-chain fatty acids, which are supposed to be positive modulators of immunity,' Segata adds. Still, he says that 'strong data' is needed to learn more about what this actually does for your gut health.
What he does know is that there's a solid link between coffee consumption and the presence of L. asaccharolyticus. Segata and fellow researchers actually fed coffee to L. asaccharolyticus that was growing in petri dishes and found it made the bacteria grow faster. 'It's clear that the coffee was stimulating it,' Segata says.
This stimulation is possibly due to metabolites in the coffee. Plus, it's 'probably not the caffeine, because decaf had a similar effect," Segata adds.
As of now, this bacterium is just linked to coffee.
However, aronia berries contain chlorogenic acid and polyphenols like coffee, so they may have a similar effect, says Danbee Kim, MD, nutrition expert, weight loss surgeon, and assistant professor at Rutgers New Jersey Medical School. 'Other foods high in chlorogenic acid—such as blueberries, apples, and pears—might also support the growth of this gut bacteria, though more research is needed to confirm this,' she says.
Having a cup or two of coffee a day promotes the growth of L.asaccharolyticus, Segata says. But he points out that 'heavy' coffee drinkers, who have three or more coffees a day, have up to 10 times more of the bacteria in their gut compared to people who don't drink coffee.
There are a few to keep in mind. The biggest potential drawback is that it could raise your risk of acid reflux, says Rudolph Bedford, MD, a gastroenterologist at Providence Saint John's Health Center in Santa Monica, CA.
'It also increases gastrointestinal mobility and can potentially cause diarrhea,' he says. But, overall, Bedford says that coffee is considered a relatively safe drink for people, provided they don't overdo it on the caffeine.
You Might Also Like
Jennifer Garner Swears By This Retinol Eye Cream
These New Kicks Will Help You Smash Your Cross-Training Goals

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NervGen Pharma to Host Virtual Investor Event
NervGen Pharma to Host Virtual Investor Event

Yahoo

time25-03-2025

  • Yahoo

NervGen Pharma to Host Virtual Investor Event

Key opinion leaders and company management will discuss the current spinal cord injury treatment landscape and NervGen's Phase 1b/2a clinical trial evaluating NVG-291 in individuals with spinal cord injury VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced that it will host a virtual investor event on Wednesday, April 9, 2025, at 10:00 a.m. ET. To register for the event, click here. The event will feature key opinion leaders, Monica Perez, PT, Ph.D. (Shirley Ryan AbilityLab) and Steven Kirshblum, MD (Rutgers New Jersey Medical School), who will join company management to discuss the unmet medical need and current treatment landscape for individuals with spinal cord injury. Ahead of clinical data expected in the second quarter for the company's Phase 1b/2a proof-of-concept, double-blind, randomized placebo-controlled clinical trial, the event will highlight the study design and provide an overview of endpoints being measured, including electrophysiology. NervGen will also review data from preclinical trials evaluating NVG-291-R and the Phase 1 trial evaluating safety of NVG-291, NervGen's first-in-class therapeutic peptide targeting nervous system repair, in chronic and subacute SCI. A live question and answer session will follow the formal presentations. About Monica A. Perez, PT, PhDMonica A. Perez, PT, PhD, is the Scientific Chair of the Arms + Hands Lab at Shirley Ryan AbilityLab, a Professor in the Department of Physical Medicine and Rehabilitation at Northwestern University, and a Research Scientist at the Edward Jr. Hines VA Hospital. Dr. Perez has studied neural mechanisms contributing to the control of voluntary movement in healthy humans and in people with spinal cord injury for more than 15 years. Her research aims to understand how the brain and spinal cord contribute to the control of movement with the ultimate goal of using this mechanistic information to develop more effective rehabilitation therapies for people with spinal cord injury. This theme is mainly investigated from a neurophysiological point of view, using a combination of transcranial magnetic stimulation, magnetic resonance imaging, electrical stimulation, and behavioral techniques. About Steven Kirshblum, MDSteven Kirshblum, MD, is a Professor and Chair of the Department of Physical Medicine and Rehabilitation at Rutgers New Jersey Medical School and the program director for the Spinal Cord Injury Medicine Fellowship. He also serves as the chief medical officer for the Kessler Foundation and the co-director of the Foundation's Tim and Caroline Reynolds Center for Spinal Stimulation. Dr. Kirshblum is the project co-director of the Northern New Jersey Spinal Cord Injury Model System, one of only 18 federally designated centers in the country. Dr. Kirshblum also serves as chief medical officer for Kessler Institute for Rehabilitation. About Phase 1b/2a TrialThe double-blind, placebo-controlled proof-of-concept Phase 1b/2a clinical trial (NCT05965700) evaluates the safety and efficacy of NVG-291 in two separate cohorts of individuals with cervical spinal cord injury: chronic (1-10 years post-injury) and subacute (20-90 days post-injury), given demonstrated efficacy in preclinical models of both chronic and acute spinal cord injury. The trial is designed to evaluate the efficacy of a fixed dose of NVG-291 using multiple clinical outcome measures as well as objective electrophysiological and MRI imaging measures and blood biomarkers that together will provide comprehensive information about the extent of recovery of function, with a focus on improvements in motor function. Specifically, the primary objective is to assess the change in corticospinal connectivity of defined upper and lower extremity muscle groups following treatment based on changes in motor evoked potential amplitudes. Secondary and exploratory objectives are to evaluate changes in a number of clinical outcome assessments focusing on motor function and strength, as well as changes in additional electrophysiological measurements. The cohorts will be comprised of approximately 20 subjects each and will be evaluated independently as the data becomes available. The trial is being partially funded by a grant from Wings for Life, which is being provided in several milestone-based payments and will offset a portion of the direct costs of this clinical trial. About NVG-291NervGen holds exclusive worldwide rights to NVG-291, a first-in-class therapeutic peptide targeting nervous system repair. NVG-291's technology was licensed from Case Western Reserve University and is based on academic studies demonstrating the preclinical efficacy of NVG-291-R, the rodent prototype of NVG-291, in animal models of spinal cord injury. Effects of NVG-291-R reported in multiple independent academic studies include the promotion of neuroplasticity, remyelination, anti-inflammatory polarization of microglia, and functional improvement in preclinical models of spinal cord injury, stroke, and peripheral nervous system injury. NVG-291 has received Fast Track designation in spinal cord injury from the U.S. Food and Drug Administration. About NervGenNervGen (TSXV: NGEN, OTCQB: NGENF) is a clinical-stage biotech company dedicated to developing innovative treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company is testing the clinical efficacy of its lead molecule, NVG-291, in a Phase 1b/2a clinical trial in spinal cord injury and has initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. For more information, visit and follow NervGen on X, LinkedIn, and Facebook for the latest news on the company. Contacts Bill Adams, Chief Financial Officerinfo@ Mike MoyerManaging Director, LifeSci Advisors, LLCmmoyer@ Schull or Ignacio Guerrero-Ros, Note Regarding Forward-Looking StatementsThis news release may contain 'forward-looking information' and 'forward-looking statements' within the meaning of applicable Canadian and United States securities legislation (collectively, 'forward-looking statements'). Such forward-looking statements herein include but are not limited to, the Company's current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements, or any other future events or developments constitute forward-looking statements, and the words 'may', 'will', 'would', 'should', 'could', 'expect', 'plan', 'intend', 'trend', 'indication', 'anticipate', 'believe', 'estimate', 'predict', 'likely' or 'potential', or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. Forward-looking statements include, without limitation, statements relating to: the subject matter to be presented at the virtual investor event; the objectives, planned clinical endpoints, timing, expected rate of enrollment, and timing of data readout and study design of our Phase 1b/2a clinical trial of NVG-291 in individuals with spinal cord injury; the development plans, timelines, expected benefits, and prospective target indications for NVG-300; the receipt of the milestone-based grant payments; and the creation of neurorestorative therapeutics to promote nervous system repair in settings of neurotrauma and neurologic disease. Forward-looking statements are based on estimates and assumptions made by the company in light of management's experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable in the circumstances. In making forward-looking statements, we have relied on various assumptions, including, but not limited to: our ability to obtain future funding on favourable terms or at all; the accuracy of our financial projections; obtaining positive results in our clinical and other trials; our ability to obtain necessary regulatory approvals; our ability to arrange for the manufacturing of our product candidates and technologies; and general business, market and economic conditions. Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements, including without limitation, a lack of revenue, insufficient funding, reliance upon key personnel, the uncertainty of the clinical development process, competition, and other factors set forth in the "Risk Factors" section of the company's most recently filed prospectus supplement, short form base shelf prospectus, annual information form, financial statements and management discussion and analysis all of which can be found on NervGen's profile on SEDAR+ at All clinical development plans are subject to additional funding. Readers should not place undue reliance on forward-looking statements made in this news release. Furthermore, unless otherwise stated, the forward-looking statements contained in this news release are made as of the date of this news release, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. The forward-looking statements contained in this news release are expressly qualified by this cautionary in to access your portfolio

A New Study Found That This Morning Beverage Can Improve Your Gut Health Almost Instantly
A New Study Found That This Morning Beverage Can Improve Your Gut Health Almost Instantly

Yahoo

time16-03-2025

  • Yahoo

A New Study Found That This Morning Beverage Can Improve Your Gut Health Almost Instantly

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Sipping on a cup of joe is an easy way to infuse some much-need pleasure into a hectic morning or slow afternoon at work. But a growing body of research suggests that coffee might do your physical health a solid, too, even helping your gut cultivate some great bacteria. A new study, which was published in Nature Microbiogy, found that a coffee habit is linked with a certain type of bacteria growth that's believed to boost your gut health. However, the link is a little complicated. So, with that in mind, here's what the study found, plus what doctors want you to know. Meet the experts: Danbee Kim, MD, nutrition expert, weight loss surgeon, and assistant professor at Rutgers New Jersey Medical School; Nicola Segata, PhD, study co-author, professor, and principal investigator at the CIBIO Department of the University of Trento; Rudolph Bedford, MD, a gastroenterologist at Providence Saint John's Health Center in Santa Monica, CA For the study, researchers analyzed fecal (i.e. poop) data from more than 20,000 people and tracked how much coffee they consumed on a daily basis. The researchers found that people who regularly drank coffee also had a bacterium called Lawsonibacter asaccharolyticus in their gut. 'People who drink coffee, on average, have a six to eight times higher amount of this bacterium in the gut,' says Nicola Segata, PhD, study co-author, professor, and principal investigator at the CIBIO Department of the University of Trento. We don't actually know a ton about L. asaccharolyticus. The bacterium was first identified in research in 2018. It produces butyrate, a sign of gut fermentation that suggests good digestion and nutrient absorption, Segata explains. "It's probably producing short-chain fatty acids, which are supposed to be positive modulators of immunity,' Segata adds. Still, he says that 'strong data' is needed to learn more about what this actually does for your gut health. What he does know is that there's a solid link between coffee consumption and the presence of L. asaccharolyticus. Segata and fellow researchers actually fed coffee to L. asaccharolyticus that was growing in petri dishes and found it made the bacteria grow faster. 'It's clear that the coffee was stimulating it,' Segata says. This stimulation is possibly due to metabolites in the coffee. Plus, it's 'probably not the caffeine, because decaf had a similar effect," Segata adds. As of now, this bacterium is just linked to coffee. However, aronia berries contain chlorogenic acid and polyphenols like coffee, so they may have a similar effect, says Danbee Kim, MD, nutrition expert, weight loss surgeon, and assistant professor at Rutgers New Jersey Medical School. 'Other foods high in chlorogenic acid—such as blueberries, apples, and pears—might also support the growth of this gut bacteria, though more research is needed to confirm this,' she says. Having a cup or two of coffee a day promotes the growth of Segata says. But he points out that 'heavy' coffee drinkers, who have three or more coffees a day, have up to 10 times more of the bacteria in their gut compared to people who don't drink coffee. There are a few to keep in mind. The biggest potential drawback is that it could raise your risk of acid reflux, says Rudolph Bedford, MD, a gastroenterologist at Providence Saint John's Health Center in Santa Monica, CA. 'It also increases gastrointestinal mobility and can potentially cause diarrhea,' he says. But, overall, Bedford says that coffee is considered a relatively safe drink for people, provided they don't overdo it on the caffeine. You Might Also Like Jennifer Garner Swears By This Retinol Eye Cream These New Kicks Will Help You Smash Your Cross-Training Goals

Scientists Just Discovered a Huge Health Benefit of Coffee
Scientists Just Discovered a Huge Health Benefit of Coffee

Yahoo

time09-03-2025

  • Yahoo

Scientists Just Discovered a Huge Health Benefit of Coffee

As if coffee drinkers needed another excuse to keep brewing their favorite cup, new research suggests that coffee is beneficial for gut health. Known for its antioxidant and anti-inflammatory properties, coffee has long been touted for its many health benefits. In fact, thousands of compounds are packed into every cup, helping to improve mental alertness, reduce inflammation, support heart health, and even ease post-workout pain. A recent study published in Nature Microbiology reveals a new benefit of coffee: It supports the growth of beneficial gut bacteria. In this study, researchers analyzed stool samples from 22,867 participants to understand the impact of coffee on gut bacteria. They categorized participants into three groups: the 'never' group (those who drink fewer than three cups per month), 'moderate' coffee drinkers (those who consumed at least three cups per month up to three cups a day), and 'heavy' coffee drinkers (those who drink three or more cups per day). Related: The Real Reason You Shouldn't Order Coffee or Tea on an Airplane The researchers found that coffee drinkers had high levels of one specific bacteria strain, L. asaccharolyticus. The results suggest that drinking coffee can have a positive effect on your gut by helping the growth of good bacteria — an exciting win for coffee drinkers. 'It turns out that the microbiome in the gut is probably way more important than we even ever expected,' says Michael Caplan, MD, clinical professor at the University of Chicago and chief scientific officer at Endeavor Health. He explains that the beneficial bacteria in our gut are essential to our overall health, and having a diverse microbiome is crucial. A healthy gut can help prevent traveler's diarrhea, antibiotic-induced diarrhea, and may even play a role in managing obesity, heart disease, and chemotherapy outcomes, according to Caplan. Our gut also houses the majority of our immune cells, making it vital to protect and maintain its strength. A healthy gut also supports digestion, reduces inflammation, and influences our thoughts. Have you ever felt nervous and noticed your gut starting to feel uneasy? Our gut and brain are closely intertwined. Dr. Chaplan points out that it's actually not only the caffeine that boosts the beneficial bacteria, as even drinking decaf coffee has a positive effect on our gut. The key contributors are likely the polyphenols, including chlorogenic acid and quinic acid, found in coffee, which help boost the growth of this beneficial bacteria. Science suggests that polyphenols act like prebiotics. They feed and encourage the growth of beneficial gut bacteria. As with any new discovery, further research is needed, especially when it comes to the potential of L. saccharolytic. Dr. Chaplan explains that this bacteria strain has only been identified in the past five years, so we don't yet fully understand how it contributes to health benefits. Could it help reduce mortality or improve outcomes in heart disease or cancer? More research is needed to understand how this bacteria could contribute to reducing disease and improving health. 'It's very safe to have one or two cups of coffee a day, and that would be enough to stimulate your intestinal flora to be poised to help you improve your long-term health,' says Dr. Caplan. This aligns with FDA recommendations, which keep caffeine intake to no more than 400 milligrams a day or about four cups of brewed coffee. Related: A New Study Says Morning Coffee Drinkers May Get More Benefits Than Those Who Sip It All Day And good news for those who love a little splash of milk or sprinkle of sugar in their coffee, the study showed that these additions don't affect the gut health benefits. This new research is exciting news for coffee drinkers, as coffee has yet to be linked to improved gut health. But don't forget about other foods and drinks that can also support a healthy gut, such as yogurt, kefir, fermented foods like kefir, kimchi and sauerkraut, and kombucha. Read the original article on Food & Wine

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store